ArticlePPAR research2026

Serum Metabolomic Profiling Reveals Potential Mechanisms and Biomarkers of Seladelpar Treatment in Patients With Primary Biliary Cholangitis.

Yun-Jung Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.